HIGHLIGHTS
- who: Hidemasa Katsumi et al. from the Department of Biopharmaceutics, Division of Clinical Pharmaceutical Sciences, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto, Japan have published the Article: L-Serine-Modified Poly-L-Lysine as a Biodegradable Kidney-Targeted Drug Carrier for the Efficient Radionuclide Therapy of Renal Cell Carcinoma, in the Journal: Pharmaceutics 2022, 1946 of /2022/
- what: The aims of this study were to develop a biodegradable kidney-targeted drug carrier using the amino_acids Ser and Lys and evaluate its efficacy as a radionuclide therapy for RCC.
SUMMARY
The authors selected . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.